NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of cancer"
DOI: 10.1002/ijc.33859
Abstract: The surface inhibitory receptor NKG2A forms heterodimers with the invariant CD94 chain and is expressed on a subset of activated CD8 T cells. As antibodies to block NKG2A are currently tested in several efficacy trials… read more here.
Keywords: cd8; inhibitory receptor; cd8 cells; nkg2a late ... See more keywords